Citigroup’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90.9K | Sell |
9,497
-6,010
| -39% | -$57.5K | ﹤0.01% | 3726 |
|
|
2025
Q1 | $144K | Sell |
15,507
-1,296
| -8% | -$12.1K | ﹤0.01% | 3623 |
|
|
2024
Q4 | $234K | Buy |
16,803
+2,136
| +15% | +$29.7K | ﹤0.01% | 3501 |
|
|
2024
Q3 | $345K | Buy |
14,667
+10,234
| +231% | +$241K | ﹤0.01% | 3229 |
|
|
2024
Q2 | $70.9K | Sell |
4,433
-2,673
| -38% | -$42.7K | ﹤0.01% | 3665 |
|
|
2024
Q1 | $117K | Buy |
7,106
+5,075
| +250% | +$83.2K | ﹤0.01% | 3494 |
|
|
2023
Q4 | $28.1K | Buy |
2,031
+2,012
| +10,589% | +$27.9K | ﹤0.01% | 4098 |
|
|
2023
Q3 | $262 | Sell |
19
-4,146
| -100% | -$57.2K | ﹤0.01% | 4522 |
|
|
2023
Q2 | $70.9K | Buy |
+4,165
| New | +$70.9K | ﹤0.01% | 3751 |
|
|
2023
Q1 | – | Sell |
-89
| Closed | -$676 | – | 4940 |
|
|
2022
Q4 | $676 | Sell |
89
-111
| -56% | -$843 | ﹤0.01% | 4674 |
|
|
2022
Q3 | $2K | Sell |
200
-734
| -79% | -$7.34K | ﹤0.01% | 4733 |
|
|
2022
Q2 | $7K | Buy |
934
+475
| +103% | +$3.56K | ﹤0.01% | 4758 |
|
|
2022
Q1 | $5K | Sell |
459
-2,706
| -85% | -$29.5K | ﹤0.01% | 5023 |
|
|
2021
Q4 | $45K | Buy |
3,165
+2,725
| +619% | +$38.7K | ﹤0.01% | 4356 |
|
|
2021
Q3 | $8K | Buy |
+440
| New | +$8K | ﹤0.01% | 4765 |
|